Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.

Clinical trial NCT04247165 · COMPLETED

Trial details

NCT number: NCT04247165
Sponsor: Herlev Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer

Start date: 2020-06-02
Primary completion: 2024-05-24
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.